ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,996.66
      1.00%
      US Tech 100
      20,874.00
      1.71%
      Dow Jones
      43,487.83
      0.78%
      Brent Oil
      80.005
      0.00%
      Bitcoin
      104,297.16
      0.15%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Brazil
      5. BOV

      6. Takeda Pharmaceutical Co (TAKP34) Quote

      Takeda Pharmaceutical Co

      Takeda Pharmaceutical Co (TAKP34)

      BOV
      80.00
      0.56
      (0.70%)
      Closed January 17 3:55PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      80.00
      Bid
      10.00
      Ask
      0.00
      Volume
      1
      80.00 Day's Range 80.00
      66.46 52 Week Range 84.50
      Market Cap
      126.594B
      Previous Close
      79.44
      Open
      80.00
      Last Trade
      1
      @
      80
      Last Trade Time
      Financial Volume
      R$ 80
      VWAP
      80.00
      Average Volume (3m)
      50
      Shares Outstanding
      1,582,419,000
      Dividend Yield
      -
      PE Ratio
      0.54
      Earnings Per Share (EPS)
      91.04
      Revenue
      4.28T
      Net Profit
      144.07B

      About Takeda Pharmaceutical Co

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Diversified
      Website
      www.takeda.co.jp
      Headquarters
      Chuo, Tokyo, Jpn
      Founded
      1984
      Takeda Pharmaceutical Co is listed in the Pharmaceutical Preparations sector of the Brazil Bovespa Exchange with ticker TAKP34. The last closing price for Takeda Pharmaceutical was R$79.44. Over the last year, Takeda Pharmaceutical shares have traded in a share price range of R$ 66.46 to R$ 84.50.

      Takeda Pharmaceutical currently has 1,582,419,000 shares outstanding. The market capitalization of Takeda Pharmaceutical is R$125.71 billion. Takeda Pharmaceutical has a price to earnings ratio (PE ratio) of 0.54.

      Ask ADVFN Intelligence (AI)

      TAKP34 Latest News

      More News
      No news to show yet.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      111.26582278481798078.95379.176DR
      4-0.48-0.59642147117380.4882.6478.951981.26549738DR
      12-1.84-2.2482893450681.8483.52785082.00700091DR
      264.86.382978723475.284.575.24780.59430017DR
      526.649.0512540894273.3684.566.467772.43435393DR
      1561.121.4198782961578.889266.018476.46818524DR
      260-3.79-4.5232127938983.79109.965.929689.28991384DR

      TAKP34 - Frequently Asked Questions (FAQ)

      What is the current Takeda Pharmaceutical share price?
      The current share price of Takeda Pharmaceutical is R$ 80.00
      How many Takeda Pharmaceutical shares are in issue?
      Takeda Pharmaceutical has 1,582,419,000 shares in issue
      What is the market cap of Takeda Pharmaceutical?
      The market capitalisation of Takeda Pharmaceutical is BRL 125.71B
      What is the 1 year trading range for Takeda Pharmaceutical share price?
      Takeda Pharmaceutical has traded in the range of R$ 66.46 to R$ 84.50 during the past year
      What is the PE ratio of Takeda Pharmaceutical?
      The price to earnings ratio of Takeda Pharmaceutical is 0.54
      What is the cash to sales ratio of Takeda Pharmaceutical?
      The cash to sales ratio of Takeda Pharmaceutical is 0.02
      What is the reporting currency for Takeda Pharmaceutical?
      Takeda Pharmaceutical reports financial results in JPY
      What is the latest annual turnover for Takeda Pharmaceutical?
      The latest annual turnover of Takeda Pharmaceutical is JPY 4.28T
      What is the latest annual profit for Takeda Pharmaceutical?
      The latest annual profit of Takeda Pharmaceutical is JPY 144.07B
      What is the registered address of Takeda Pharmaceutical?
      The registered address for Takeda Pharmaceutical is 4-1-1 DOSHOMACHI, CHUO-KU, CHUO, TOKYO, 540-8645
      What is the Takeda Pharmaceutical website address?
      The website address for Takeda Pharmaceutical is www.takeda.co.jp
      Which industry sector does Takeda Pharmaceutical operate in?
      Takeda Pharmaceutical operates in the PHARMACEUTICAL DIVERSIFIED sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AGXY3Agrogalaxy Participacoes SA
      R$ 0.72
      (63.64%)
      		3.38M
      CGAS3Cia Gas Sao Paulo Comgas
      R$ 158.97
      (30.10%)
      		300
      SEQL3Sequoia Logistica e Transportes SA
      R$ 3.32
      (13.31%)
      		1.58M
      AMAR11Lojas Marisa S.A.
      R$ 0.57
      (9.62%)
      		20.2k
      FICT3Fictor Alimentos S.A.
      R$ 3.28
      (9.33%)
      		83k
      DASA11Diagnosticos da America S.A
      R$ 0.70
      (-22.22%)
      		500
      BIOM11Biomm SA
      R$ 0.99
      (-17.50%)
      		1.5k
      ESTR4Manufatura Brinquedos Estrela Sa
      R$ 3.56
      (-11.00%)
      		1.5k
      NORD3Nordon Inds Metalurgicas Sa
      R$ 6.10
      (-7.58%)
      		700
      YDUQ3YDUQS Participacoes S.A.
      R$ 8.58
      (-5.71%)
      		12.55M
      BBDC4Bco Bradesco Sa
      R$ 11.59
      (-1.19%)
      		60.74M
      HAPV3Hapvida Participacoes Investimento SA
      R$ 2.24
      (-5.49%)
      		58.19M
      VALE3Vale SA
      R$ 54.49
      (3.46%)
      		54.66M
      ABEV3Ambev SA
      R$ 11.09
      (0.09%)
      		51.43M
      COGN3CognaEducacao SA
      R$ 1.25
      (1.63%)
      		41.06M

      Discussion

      View Full Feed
      MomsSpaghetti MomsSpaghetti 3 minutes ago
      I don't know but it could be any one of these to be honest:

      The Motley Fool

      Seeking Alpha

      Benzinga

      Zacks

      Morningstar, Inc.

      Morning Brew

      Morningstar Investor

      Kiplinger
      MNMD
      Imindog Imindog 3 minutes ago
      Nice s-1 diluting another 15 million shares!! Also check out the section where it states as of January 2025 Iqst do not have an established source of revenues to cover operating costs!! So what does that tell you boys and girls? Well I’ll tell ya they are still losing money and can’t keep the lights
      IQST
      ison929 ison929 3 minutes ago
      Nice day...
      NWBO
      zab zab 4 minutes ago
      Wyoming,  Montana,  Alaska,  new Mexico,  and North Dakota, are the top 5 states for suicide. 
      zab zab 7 minutes ago
      The top 10 states for committing suicide are all RED states. Wyoming is # 1
      100lbStriper 100lbStriper 7 minutes ago
      it goes down this year.................we are on step 5.......i dont see the supreme court in the picture, but wtf knows.........

      https://charts.stocktwits-cdn.com/production/original_600572084.png
      NLST
      Doc logic Doc logic 7 minutes ago
      Investor082,

      I don’t need to give any excuses. I expect NHS to pay for 600+\- UK patients plus worldwide self pay but am targeting the 600+\- patient count only with self pay included as the more conservative approach. I also expect that Flaskworks will be close to being available b
      AZN NWBO
      SCAMBUSTERKING SCAMBUSTERKING 10 minutes ago
      He cant even file the TA lawsuit timely, how do you think he is going to get this trading and anyone in OTC want to buy it? Literally all of OTC hates him and knows he a securities fraudster. He literally will be going to jail over all of this in the next few years. There isnt one paid promo group t
      BCAP
      chen1992 chen1992 11 minutes ago
      By the next market opening, we will have a new president. I wish you all the best this 2025
      TGLO
      sissyjane1 sissyjane1 11 minutes ago
      wow all sells no buys , no news....no people
      BNCM
      WinstonCup WinstonCup 11 minutes ago
      Terrible trading share volume day today. Mostly all sells, people dumping this POS.
      WDLF
      Hoghead7 Hoghead7 12 minutes ago
      Still perplexed!
      FCEL down just over 2% when including after hours
      On low volume (under 1M shares).
      PLUG down 11% on heavy volume, even after getting low interest loan from DOE!
      BE up slightly on above average volume
      BLDP down 3% then up fractionally after hours
      BLDP FCEL
      Signor Signor 13 minutes ago
      Did we get some dividends???
      RNVA
      michael702/ michael702/ 14 minutes ago
      Just haven't heard anything from BLLB for whatever reason
      BLLB
      Stinger2014 Stinger2014 14 minutes ago
      I thought he got a sign? 😊
      CGAC
      rbtree rbtree 16 minutes ago
      You really should go back to bed for a few months. With any luck, you may awaken with a few functioning brain cells.

      But you likely won't.

      So, keep posting. The board needs a fool to laugh at.
      AABB
      qtdecker qtdecker 16 minutes ago
      https://www.etfdailynews.com/2025/01/17/capital-investment-advisors-llc-acquires-shares-of-61500-lightwave-logic-inc-nasdaqlwlg/
      LWLG
      JPetroInc JPetroInc 17 minutes ago
      what’s it going to be boys…?

      Jul 31st - 1st Spaces X conference call
      Oct 21st - 2nd Spaces X conference call
      Jan ___ - 3rd Spaces X conference call

      heading into 3rd Qtr for the new & improved MONI

      BAF $MONI
      MONI
      Eli's Gone Eli's Gone 17 minutes ago
      Mets can make a rotation from the coming Dodger castoffs---unless the Blue go to a 9 man rotation :-)
      winstocksnew winstocksnew 18 minutes ago
      Nice!
      RITE
      Zorax Zorax 18 minutes ago
      Makes my conspiracy shackles come up... what if the gop nazi's had a plant in the campaign group?
      They should have flipped and had walz run with Harris as VP again. He would have won. No anti-woman anti-black non voters that killed us.

      It was too much to ask 20 or 30 million br
      OMOLIVES OMOLIVES 18 minutes ago
      Correct. That purchase was never completed. Every business acquisition was merely a lease. All of them with the exception of the collectibles. Ixaya was the most obvious. They leased revenue and assets were applicable. And everyone just fn' ignored it..lol.
      HMBL
      PlaceboJeffect PlaceboJeffect 19 minutes ago
      True, but there are way way better set ups out there and way better charts. Phil will never be apart of a run again until he reverse splits and waits for bottom. Too many shares, too many false and misleading promises, too many bears ready to dump, too many bashers. This ain't it.

      Go
      PHIL
      winstocksnew winstocksnew 19 minutes ago
      See their investor relations page:
      The company is very transparent and they seek to provide honest, timely and thoughtful feedback.

      https://mineral-rite.com/investor-relations/
      RITE
      ProfitScout ProfitScout 20 minutes ago
      I can tell you that none of my IVDN shares are up for sale at this time. From the news we have been seeing, especially the company's latest announcement below, 2025 should show stronger and stronger sales results and all time record revenue generation here. There are a number of factors that have
      IVDN

      Your Recent History

      BOV
      TAKP34
      Takeda Pharmaceutical
      AQSE
      PCTN.GB
      Picton Property Income
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads